Juvenile dermatomyositis. Pathophysiology and disease expression (Q40417096)

20 September 2017

1 reference

title

Juvenile dermatomyositis. Pathophysiology and disease expression (English)

1 reference

20 September 2017

0 references

Pachman LM

1

1 reference

20 September 2017

publication date

1 October 1995

1 reference

Pediatric Clinics of North America

20 September 2017

published in

1 reference

20 September 2017

volume

42

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

1071-1098

1 reference

Dermatomyostis of childhood, ultrastructural alteratious of muscle and intramuscular blood vessels

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Dermatomyositis (systemic angiopathy) of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Dermatomyositis and malignancy. A review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Complement abnormalities in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Treatment of calcinosis universalis with low-dose warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

1 reference

7 January 2021

Polymyositis and dermatomyositis (first of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Ureteral necrosis in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Pneumatosis intestinalis in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Carnitine--metabolism and functions

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

The rashes of dermatomyositis in a black patient

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

The childhood type of dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Distribution of capillaries in normal and diseased human skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

DERMATOMYOSITIS AND FOCAL SCLERODERMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Microvascular changes in early and advanced dermatomyositis: a quantitative study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Tubuloreticular structures (TRS) and cylindric confronting cisternae (CCC) in childhood dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Spontaneous regression of retinal neovascularisation in juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Immunogenetic studies of juvenile dermatomyositis: HLA-DR antigen frequencies.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Immunogenetic studies of juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Diagnosis of inflammatory myopathy by percutaneous needle biopsy with demonstration of the focal nature of myositis.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Childhood dermatomyositis in monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Immunopathologic study of skin lesions in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Juvenile dermatomyositis: a statistical study of 114 patients with dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Elevated serum immunoglobulin E levels in patients with juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Mortality from polymyositis and dermatomyositis in the United States, 1968-1978.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Treatment of duodenocutaneous fistula with somatostatin analog in a child with dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Lymphotoxin formation by lymphocytes and muscle in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Creatine kinase activity inhibitor in sera from patients with muscle disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Microvascular deposition of complement membrane attack complex in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Childhood polymyositis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Polymyositis-dermatomyositis and malignant lesions: does an association exist?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Treatment of dermatomyositis with intravenous gammaglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Failure of warfarin in treatment of calcinosis universalis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Aggressive therapy for childhood rheumatic diseases. When are immunosuppressives appropriate?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Gamma-carboxyglutamate excretion and calcinosis in juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

The presence of gamma-carboxyglutamic acid in the proteins associated with ectopic calcification

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

The enzymology of skeletal muscle disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Evidence for seasonal variation in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Autoantibodies in juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Recurrent juvenile dermatomyositis and cutaneous necrotizing arteritis with molecular mimicry between streptococcal type 5 M protein and human skeletal myosin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Chronic enteroviral meningoencephalitis in agammaglobulinemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Changing electromyographic findings during the chronic course of polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

The epidemiology of polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

The myositis of influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Methotrexate treatment of recalcitrant childhood dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Serial changes in nailfold capillary morphology in childhood dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Juvenile dermatomyositis: a clinical and immunologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Immunogenetic studies of juvenile dermatomyositis. III. Study of antibody to organ-specific and nuclear antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Chronic graft versus host disease presenting with polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Acute Hepatitis B Simulating Dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Molecular genetic studies of major histocompatibility complex genes in children with Juvenile dermatomyositis: Increased risk associated with HLA-DQA1∗0501

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Myositis of chronic graft versus host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Reversal of chronic polymyositis following intravenous immune serum globulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Evidence for a novel picornavirus in human dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Polymyositis accompanying Coxsackie virus B2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Juvenile dermatomyositis induced by toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Activation of complement and coagulation in juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Childhood polymyositis as a paraneoplastic phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Course of treated juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Nailfold capillary abnormalities and clinical outcome in childhood dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: dermatomyositis sine myositis?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Prognosis in juvenile dermatopolymyositis: a cooperative retrospective study of 70 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Chronic myopathy associated with coxsackievirus type A9. A combined electron microscopical and viral isolation study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Laboratory manifestations of polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

The association between Mi-2 antibodies and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Coxsackie B neutralisation titres in polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Echovirus encephalitis and myositis in primary immunoglobulin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Vascular Deposits of Immunoglobulin and Complement in Idiopathic Inflammatory Myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Perifascicular atrophic fibers in childhood dermatomyositis with particular reference to mitochondrial changes

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Recurrent photosensitive dermatitis preceding juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2940054-4

7 January 2021

10.1016/S0031-3955(16)40054-4

Identifiers

DOI

0 references

1 reference